XML 102 R88.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SEGMENT INFORMATION - Narrative (Details)
3 Months Ended
Mar. 31, 2024
Salix | Xifaxan Branded Products | Revenue from Contract with Customer, Segment Benchmark | Product Concentration Risk  
Segment reporting information  
Concentration risk percentage 80.00%